POWER

THE LAB

WITH

LabXTM

Scroll down for more information

One for All. All for One.

LabX Laboratory Software connects to multiple METTLER TOLEDO lab instruments. Benefit from increased workflow efficiency, optimal security support and centralised management of one or multiple instruments, users and data.

Maximum Security

LabX fully supports the current requirements of regulatory bodies. Security features such as electronic signatures and an Audit Trail makes your lab  system audit-ready at any time.

• Audit Trail   

• Electronic Signatures

• User Rights

Click here to find out more 

Data Integrity

All generated data and metadata such as date and time, user information and instrument status are safely stored in the central database. LabX tracks your data all the way from origin to storage.

• Covers all points of ALCOA and ALCOA+

• Centrally store complete data including metadata

Click here to find out more 

Regulatory Support

Built-in security features such as electronic signatures and user management options assist you in complying with regulations and ensure your lab is audit-ready at all times.

• Secure database, full traceability

• Audit Trail

• Management of instrument tests

• User rights

• Review / approve data

Find out more 

➤ www.mt.com/labx

Go to article: Home | Catching the next Covid-19 variantGo to article: In this issueGo to article: ContentsGo to article: HOF Sonderanlagenbau Company Insight Go to article: HOF SonderanlagenbauGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: Mettler Toledo Company InsightGo to article: Data Integrity Solutions – METTLER TOLEDOGo to article: CommentGo to article: New coronavirus variant causing concern as cases spike in South AfricaGo to article: Teva and MedinCell looking to enter LAI schizophrenia marketGo to article: Lack of injectable anti-HIV therapies in the Japanese marketGo to article: Prevention of thrombosis in Covid-19 patientsGo to article: T2D therapy accepted into FDA Emerging Technology ProgramGo to article: Owen Mumford Company Insight Go to article: Owen MumfordGo to article: ButterworthGo to article:  Molnár-Institute Company Insight Go to article: Molnar-InstituteGo to article: In DepthGo to article: Enter Amazon Pharmacy: the beginning of a great online pharmacy fight?Go to article: Covid-19 vaccines have made treating racism in medicine even more urgentGo to article: Could Covid-19 give pharma the chance for the ultimate image makeover?Go to article: Delivering a billion doses with the UK VMICGo to article: Tackling the ‘silent pandemic’ of AMR: WHO launches the Global Leaders GroupGo to article: Saxenda: profiling the first NHS weight loss drug for a decadeGo to article: How real-time genomic surveillance could spot new Covid-19 variantsGo to article: A new hope for slowing disability in MSGo to article: DatwylerGo to article: Datwyler Company Insight Go to article: ACG WorldwideGo to article: Gemini Data LoggersGo to article: In DataGo to article: Inside the dealGo to article: Deals analysisGo to article: The pharma industry key listGo to article: Global markets and indicesGo to article:  Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: EventsGo to article: Next issue